Gerben J.C. Zwezerijnen

Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index

N. George Mikhaeel, Martijn W. Heymans, Jakoba J. Eertink et al. · Journal of Clinical Oncology · 2022 · 149 citations · Full text

Medicine, Biostatistics, Oncology +17

18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma

Jakoba J. Eertink, Tim van de Brug, Sanne E. Wiegers et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 146 citations · Full text

Medicine, Oncology, Radiology +17

Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium

Sally F. Barrington, Gerben J.C. Zwezerijnen, Henrica C. W. de Vet et al. · Journal of Nuclear Medicine · 2020 · 113 citations · Full text

Medicine, Oncology, Radiology +17

Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

B.H.E. Jansen, Yves J. L. Bodar, Gerben J.C. Zwezerijnen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 107 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients

Jakoba J. Eertink, Martijn W. Heymans, Gerben J.C. Zwezerijnen et al. · EJNMMI Research · 2022 · 66 citations · Full text

Medicine, Biostatistics, Oncology +14